Travis Newsom
Family · Pocatello, IDNPI 1053093336
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,467 of the $6,365 with a category attached, or 85.9%. It is spread thinly across 45 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $34.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$780
- Johnson & Johnson$598
- Myriad Genetic Laboratories, Inc.$507
- Pfizer$468
- Lilly USA, LLC$451
- Novartis$363
- plus $3K from 39 others
What the payments were for
- Food & beverage$5,46786%
- Education$89814%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,365 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 15 | $3,722 |
| Ondansetron OdtOndansetron | 49 | $726 |
| Prochlorperazine Maleate | 43 | $572 |
| Tamoxifen Citrate | 18 | $515 |
| Acyclovir | 22 | $477 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $468 |
| Potassium Chloride | 23 | $467 |
| Anastrozole | 23 | $462 |
| Oxycodone Hcl | 14 | $246 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $189 |
| Megestrol Acetate | 12 | $169 |
| Letrozole | 14 | $154 |
| Gabapentin | 21 | $147 |
| Prednisone | 19 | $116 |
| Cyclobenzaprine Hcl | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Other family in Pocatello
- Jessicka PricePocatello$11K
- Ruth DekkerPocatello$10K
- Rebekah LuceroPocatello$7K
- Stacy JamesPocatello$5K
- Paul BowersPocatello$4K
- Bobbi BullockNampa$609K
- Michael ParkerMeridian$69K
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Alysha SchlackNampa$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.